1. Home
  2. GMED vs BIO Comparison

GMED vs BIO Comparison

Compare GMED & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • BIO
  • Stock Information
  • Founded
  • GMED 2003
  • BIO 1952
  • Country
  • GMED United States
  • BIO United States
  • Employees
  • GMED N/A
  • BIO N/A
  • Industry
  • GMED Medical/Dental Instruments
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • GMED Health Care
  • BIO Industrials
  • Exchange
  • GMED Nasdaq
  • BIO Nasdaq
  • Market Cap
  • GMED 11.6B
  • BIO 9.1B
  • IPO Year
  • GMED 2012
  • BIO N/A
  • Fundamental
  • Price
  • GMED $88.11
  • BIO $342.01
  • Analyst Decision
  • GMED Buy
  • BIO Strong Buy
  • Analyst Count
  • GMED 13
  • BIO 4
  • Target Price
  • GMED $95.42
  • BIO $414.00
  • AVG Volume (30 Days)
  • GMED 1.0M
  • BIO 158.1K
  • Earning Date
  • GMED 02-20-2025
  • BIO 02-13-2025
  • Dividend Yield
  • GMED N/A
  • BIO N/A
  • EPS Growth
  • GMED N/A
  • BIO N/A
  • EPS
  • GMED 0.67
  • BIO N/A
  • Revenue
  • GMED $2,478,596,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • GMED $62.39
  • BIO N/A
  • Revenue Next Year
  • GMED $6.71
  • BIO $2.92
  • P/E Ratio
  • GMED $131.18
  • BIO N/A
  • Revenue Growth
  • GMED 102.10
  • BIO N/A
  • 52 Week Low
  • GMED $49.33
  • BIO $262.12
  • 52 Week High
  • GMED $90.48
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • GMED 69.74
  • BIO 53.78
  • Support Level
  • GMED $86.28
  • BIO $335.42
  • Resistance Level
  • GMED $90.48
  • BIO $351.96
  • Average True Range (ATR)
  • GMED 1.86
  • BIO 9.09
  • MACD
  • GMED 0.46
  • BIO 2.06
  • Stochastic Oscillator
  • GMED 73.98
  • BIO 59.23

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: